Delivery Order SPE2DB20D2104-SPE2DB23FS53C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,956.08 firm fixed-price delivery order is for the supply of Testosterone Cypionate 200 mg/mL, a critical medical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,015.68 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/ml medication. The contract has an ultimate completion date of October 27, 2023 and was awarded on October 26, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.42 delivery order is for the supply of 200 mg/ml testosterone cypionate, a specialty medication. The contract is a firm-fixed-price delivery order with a period of performance through February 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award, valued at $1,416.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 7, 2025 and uses a Firm Fixed Price pricing type. It is not designated with a set-aside requirement, indicating...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.58, is for the delivery of Testosterone Cypionate 200 mg/mL, a prescription medication. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a key vendor supporting federal medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.32 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL, a pharmaceutical product. The contract is not set-aside and has an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,108.44 firm fixed-price delivery order is for the delivery of 4,560,222,426 units of Testosterone Cypionate 2,000 mg/10 mL 10 mL. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of...
- This federal contract award, valued at $1,993.36, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone Cypionate 200 mg/mL, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,177.00 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL medication. The award has a ceiling value of $1,177.00 and an ultimate completion date of November 20, 2024. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is the...
- This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.51 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS53CDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.83 delivery order covers the supply of testosterone cypionate 200 mg/mL medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen is a critical vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical systems, leveraging its extensive pharmaceutical distribution capabilities to efficiently fulfill government requirements for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/8/23 |